Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG.

Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang RW, Dickinson M, Ng A, Roberts KB, Gao S, Balogh AG, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis S, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani R, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT.

Blood. 2020 Mar 25. pii: blood.2019003877. doi: 10.1182/blood.2019003877. [Epub ahead of print]

PMID:
32211877
2.

Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis.

Saleem A, Natkunam Y.

Int J Mol Sci. 2020 Feb 22;21(4). pii: E1501. doi: 10.3390/ijms21041501. Review.

3.

Genetic Subtypes of Systemic Anaplastic Large Cell Lymphoma Show Distinct Differences in PD-L1 Expression and Regulatory and Cytotoxic T Cells in the Tumor Microenvironment.

Ferreira CR, Manohar V, Zhao S, Bangs CD, Cherry A, Azevedo RS, Lage LAPC, Pereira J, Zerbini MCN, Gratzinger D, Natkunam Y.

Appl Immunohistochem Mol Morphol. 2020 Jan;28(1):10-16. doi: 10.1097/PAI.0000000000000798.

PMID:
31809310
4.

Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.

Ferreira CR, Zhao S, Sanches JA, Miyashiro D, Cury-Martins J, Azevedo RS, Zerbini MCN, Natkunam Y, Gratzinger D.

Diagn Pathol. 2019 Oct 22;14(1):115. doi: 10.1186/s13000-019-0900-7.

5.

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

Rosenwald A, Bens S, Advani R, Barrans S, Copie-Bergman C, Elsensohn MH, Natkunam Y, Calaminici M, Sander B, Baia M, Smith A, Painter D, Pham L, Zhao S, Ziepert M, Jordanova ES, Molina TJ, Kersten MJ, Kimby E, Klapper W, Raemaekers J, Schmitz N, Jardin F, Stevens WBC, Hoster E, Hagenbeek A, Gribben JG, Siebert R, Gascoyne RD, Scott DW, Gaulard P, Salles G, Burton C, de Jong D, Sehn LH, Maucort-Boulch D.

J Clin Oncol. 2019 Dec 10;37(35):3359-3368. doi: 10.1200/JCO.19.00743. Epub 2019 Sep 9.

6.

Additional considerations related to the elusive boundaries of EBV-associated T/NK-cell lymphoproliferative disorders.

Fernandez-Pol S, Silva O, Natkunam Y.

Haematologica. 2019 Mar;104(3):e125-e126. doi: 10.3324/haematol.2019.216556. No abstract available.

7.

Myeloid Cell Nuclear Differentiation Antigen (MNDA) Positivity in Primary Follicles: Potential Pitfall in the Differential Diagnosis With Marginal Zone Lymphoma.

Manohar V, Peerani R, Tan B, Gratzinger D, Natkunam Y.

Appl Immunohistochem Mol Morphol. 2019 Jan 11. doi: 10.1097/PAI.0000000000000738. [Epub ahead of print]

PMID:
30640752
8.

Immune checkpoint blockade as a potential therapeutic strategy for undifferentiated malignancies.

Devereaux KA, Charu V, Zhao S, Charville GW, Bangs CD, van de Rijn M, Cherry AM, Natkunam Y.

Hum Pathol. 2018 Dec;82:39-45. doi: 10.1016/j.humpath.2018.06.034. Epub 2018 Jul 7.

PMID:
30539796
9.

High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti-CD74-drug conjugate.

Zhao S, Molina A, Yu A, Hanson J, Cheung H, Li X, Natkunam Y.

J Pathol Clin Res. 2019 Jan;5(1):12-24. doi: 10.1002/cjp2.114. Epub 2018 Oct 8.

10.

Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.

Lo Bello G, Akarca AU, Ambrosio MR, Agostinelli C, Molina-Kirsch H, Ramsay A, Rodriguez-Justo M, Pugh M, Zhao S, DeLisser M, Sabattini E, Dojcinov S, Pileri SA, Natkunam Y, Leoncini L, Marafioti T.

Virchows Arch. 2018 Dec;473(6):749-757. doi: 10.1007/s00428-018-2434-x. Epub 2018 Aug 27.

11.

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D.

Blood. 2018 Nov 1;132(18):1871-1878. doi: 10.1182/blood-2018-04-842559. Epub 2018 Aug 6. Review.

12.

Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens.

Fernandez-Pol S, van de Rijn M, Natkunam Y, Charville GW.

Virchows Arch. 2018 Dec;473(6):765-769. doi: 10.1007/s00428-018-2410-5. Epub 2018 Jul 17.

PMID:
30014288
13.

FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the spectrum of T-cell lymphomas with regulatory phenotype.

Ferreira CR, Zhao S, Sahoo MK, Pinsky B, Weber J, Lage LAPC, Pereira J, Zerbini MCN, Natkunam Y.

Hum Pathol. 2018 Oct;80:138-144. doi: 10.1016/j.humpath.2018.06.001. Epub 2018 Jun 10.

PMID:
29898383
14.

Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.

García-Ramírez I, Bhatia S, Rodríguez-Hernández G, González-Herrero I, Walter C, González de Tena-Dávila S, Parvin S, Haas O, Woessmann W, Stanulla M, Schrappe M, Dugas M, Natkunam Y, Orfao A, Domínguez V, Pintado B, Blanco O, Alonso-López D, De Las Rivas J, Martín-Lorenzo A, Jiménez R, García Criado FJ, García Cenador MB, Lossos IS, Vicente-Dueñas C, Borkhardt A, Hauer J, Sánchez-García I.

EMBO J. 2018 Jul 13;37(14). pii: e98783. doi: 10.15252/embj.201798783. Epub 2018 Jun 7.

15.

Defining the elusive boundaries of chronic active Epstein-Barr virus infection.

Fernandez-Pol S, Silva O, Natkunam Y.

Haematologica. 2018 Jun;103(6):924-927. doi: 10.3324/haematol.2018.193714. No abstract available.

16.

Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin.

Satpathy AT, Brown RA, Gomulia E, Briseño CG, Mumbach MR, Pan Z, Murphy KM, Natkunam Y, Chang HY, Kim J.

Mod Pathol. 2018 Sep;31(9):1479-1486. doi: 10.1038/s41379-018-0052-4. Epub 2018 May 9.

17.

KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.

Kunder CA, Roncador G, Advani RH, Gualco G, Bacchi CE, Sabile JM, Lossos IS, Nie K, Tibshirani RJ, Green MR, Alizadeh AA, Natkunam Y.

Am J Clin Pathol. 2017 Nov 20;148(6):465-476. doi: 10.1093/ajcp/aqx099.

18.

Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes.

Panjwani PK, Charu V, DeLisser M, Molina-Kirsch H, Natkunam Y, Zhao S.

Hum Pathol. 2018 Jan;71:91-99. doi: 10.1016/j.humpath.2017.10.029. Epub 2017 Nov 6.

PMID:
29122656
19.

Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors.

Chisholm KM, Krishnan C, Heerema-McKenney A, Natkunam Y.

Pediatr Dev Pathol. 2017 Jun;20(3):213-223. doi: 10.1177/1093526616689642. Epub 2017 Feb 10.

PMID:
28521631
20.

Unifying mechanism for different fibrotic diseases.

Wernig G, Chen SY, Cui L, Van Neste C, Tsai JM, Kambham N, Vogel H, Natkunam Y, Gilliland DG, Nolan G, Weissman IL.

Proc Natl Acad Sci U S A. 2017 May 2;114(18):4757-4762. doi: 10.1073/pnas.1621375114. Epub 2017 Apr 19.

Supplemental Content

Loading ...
Support Center